BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5344871)

  • 21. The mode of action of beta-benzal butyric acid, an hypocholesterolemic drug, in affecting mitochondrial respiration.
    Speranza ML; Gaiti A; Nessi R; Binaglia L; Porcellati G
    Biochem Pharmacol; 1971 Sep; 20(9):2477-84. PubMed ID: 4355784
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of a terminal period of fasting on the serum and tissue lipid effects of ethyl chlorophenoxyisobutyrate (CPIB).
    Duncan CH; Best MM
    Metabolism; 1968 Aug; 17(8):681-9. PubMed ID: 5676214
    [No Abstract]   [Full Text] [Related]  

  • 23. Mode of action of chlorophenoxyisobutyric acid on cholesterol metabolism in man.
    Horlick L; Kudchodkar BJ; Sodhi HS
    Circulation; 1971 Feb; 43(2):299-309. PubMed ID: 5540713
    [No Abstract]   [Full Text] [Related]  

  • 24. HCG 004, a new highly potent hypolipidaemic drug.
    Granzer E; Nahm H
    Arzneimittelforschung; 1973 Sep; 23(9):1353-4. PubMed ID: 4801238
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacological study of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminium. I. The effect of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminum on lipid metabolism in normal rats.
    Tomita T; Takeshita R; Nagakura T; Hayashi E
    Jpn J Pharmacol; 1973 Jun; 23(3):281-7. PubMed ID: 4541943
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of ethyl-alpha-p-chlorophenoxybutyrate (CPIB) on total cholesterol concentrations of rat aorta.
    Tolman EL; Tepperman J; Tepperman HM
    Proc Soc Exp Biol Med; 1969 Dec; 132(3):936-9. PubMed ID: 5361014
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum lipid responses to ethyl-p-chlorophenoxyisobutyrate with different dietary fats.
    Kokatnur MG; Malcom GT; Martinez RD
    Metabolism; 1969 Jan; 18(1):73-80. PubMed ID: 5764810
    [No Abstract]   [Full Text] [Related]  

  • 28. Influence of 4,4'-(isopropylidenedithio)bis(2,6-di-t-butylphenol) (DH-581) on experimental atherosclerosis in rabbits.
    Kritchevsky D; Kim HK; Tepper SA
    Proc Soc Exp Biol Med; 1971 Apr; 136(4):1216-21. PubMed ID: 5554467
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of N( -methylbenzyl)linoleamide upon cholesterol metabolism in rats.
    Kritchevsky D; Tepper SA
    Arzneimittelforschung; 1971 Jul; 21(7):1024-6. PubMed ID: 5109487
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of N-cyclohexyl linoleamide on cholesterol metabolism in rats.
    Kritchevsky D; Sallata P; Tepper SA
    Proc Soc Exp Biol Med; 1968 Jan; 127(1):132-5. PubMed ID: 5644631
    [No Abstract]   [Full Text] [Related]  

  • 31. Biosynthesis of cholesterol by the bovine aorta and the mechanism of action of alpha-para-chlorophenoxyisobutyric acid.
    Walsh MR; Teal SW; Gamble W
    Arch Biochem Biophys; 1969 Mar; 130(1):7-18. PubMed ID: 5778686
    [No Abstract]   [Full Text] [Related]  

  • 32. Lipid lowering influence of ethyl p-chlorophenoxyisobutyrate in liver of rats fed high fat diets.
    Kokatnur MG; Malcom GT
    Metabolism; 1970 Feb; 19(2):120-8. PubMed ID: 5410942
    [No Abstract]   [Full Text] [Related]  

  • 33. Changes in the weight and composition of the liver in the rat, dog and monkey treated with ethyl chlorophenoxyisobutyrate.
    Platt DS; Thorp JM
    Biochem Pharmacol; 1966 Jul; 15(7):915-25. PubMed ID: 4961207
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of 3-hydroxy-3-methylglutaric acid on blood lipids in normal and cholesterol-fed rats.
    Beg ZH; Siddiqi M
    Experientia; 1968 Aug; 24(8):791-2. PubMed ID: 5683167
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of the hypocholesterolemic drug, AY 9944, on the absorption of retinol in the rat.
    Alam NA; Glover J
    Int Z Vitaminforsch; 1970; 40(3):291-8. PubMed ID: 5450992
    [No Abstract]   [Full Text] [Related]  

  • 36. Decrease of ethanol-induced fatty liver by ethyl alpha-p-chlorophenoxyisobutyrate.
    Spritz N; Lieber CS
    Proc Soc Exp Biol Med; 1966 Jan; 121(1):147-9. PubMed ID: 5902917
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of two substituted valeric acid derivatives on cholesterol metabolism in rats.
    Kritchevsky D; Tepper SA; Story JA
    Proc Soc Exp Biol Med; 1974 Jan; 145(1):12-7. PubMed ID: 4812849
    [No Abstract]   [Full Text] [Related]  

  • 38. Atromid-S for the reduction of plasma lipids.
    Med Lett Drugs Ther; 1967 Jun; 9(12):45-7. PubMed ID: 6037633
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on the mode of action of clofibrate: effects on hormone-induced changes in plasma free fatty acids, cholesterol, phospholipids and total esterified fatty acids in rats and dogs.
    Barrett AM; Thorp JM
    Br J Pharmacol Chemother; 1968 Feb; 32(2):381-91. PubMed ID: 4296427
    [No Abstract]   [Full Text] [Related]  

  • 40. The effects of certain hypocholesterolemic agents on hepatic delta-aminolevulinic acid synthetase levels in mice.
    Weissman EB; Cheng LC; Orten JM
    Proc Soc Exp Biol Med; 1974 Feb; 145(2):438-41. PubMed ID: 4814138
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.